Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.79999 | 63 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.7848 | 63 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.75494 | 63 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.68637 | 62 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.7085 | 63 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.8141 | 63 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.83797 | 63 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.74237 | 63 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.76072 | 63 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.74524 | 63 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.78171 | 63 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.76202 | 63 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.96982 | 66 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.77062 | 63 |